Breast tumor clinicopathologic features | LEP | LEPR | ADIPOQ | ADIPOR1 | ADIPOR2 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Diff of LS means (SE) | P | Diff of LS means (SE) | P | Diff of LS means (SE) | P | Diff of LS means (SE) | P | Diff of LS means (SE) | P | |
Tumor grade | ||||||||||
 Moderately vs. well differentiated | − 8.20 (3.68) | 0.03 | − 4.99 (3.61) | 0.17 | − 6.85 (5.06) | 0.18 | − 4.42 (4.99) | 0.38 | − 5.95 (5.01) | 0.24 |
 Poorly vs. well differentiated | − 5.50 (3.44) | 0.11 | − 9.03 (3.38) | 0.008 | − 5.59 (4.76) | 0.24 | − 2.03 (4.69) | 0.66 | − 0.37 (4.71) | 0.94 |
Tumor size | ||||||||||
 1.0–2.0 cm vs. < 1.0 cm | − 0.84 (3.07) | 0.78 | 1.99 (3.06) | 0.52 | − 7.80 (4.01) | 0.05 | − 6.58 (4.19) | 0.12 | − 6.37 (4.02) | 0.11 |
 > 2.0 cm vs. < 1.0 cm | 0.05 (3.01) | 0.99 | − 2.04 (3.01) | 0.50 | − 6.28 (3.94) | 0.11 | − 3.07 (4.13) | 0.46 | 3.29 (3.96) | 0.41 |
AJCC stage | ||||||||||
 Stage I vs. stage 0 | 7.38 (4.25) | 0.08 | − 0.01 (4.12) | 0.99 | 1.43 (5.36) | 0.79 | 10.34 (5.57) | 0.06 | 2.12 (5.46) | 0.70 |
 Stage II vs. stage 0 | 5.17 (4.20) | 0.22 | − 2.67 (4.08) | 0.51 | − 2.89 (5.28) | 0.58 | 4.91 (5.49) | 0.37 | 3.09 (5.38) | 0.57 |
 Stage III/IV vs. stage 0 | 1.38 (4.73) | 0.77 | − 7.55 (4.65) | 0.10 | − 5.76 (6.06) | 0.34 | 4.63 (6.30) | 0.46 | 4.90 (6.18) | 0.43 |
Lymph node status | ||||||||||
 Positive vs. negative | − 0.79 (2.39) | 0.74 | 1.52 (2.33) | 0.51 | − 0.21 (3.13) | 0.95 | − 1.15 (3.22) | 0.72 | − 4.35 (3.12) | 0.16 |
Ki67 status | ||||||||||
 Ki67+/unfavorable vs. Ki67−/favorable | 1.76 (2.26) | 0.44 | − 4.82 (2.34) | 0.04 | − 8.95 (3.44) | 0.01 | − 4.49 (3.64) | 0.22 | 0.53 (3.59) | 0.88 |
ER status | ||||||||||
 ER− vs. ER+ | − 3.22 (2.27) | 0.16 | − 9.98 (2.32) | < 0.0001 | − 2.21 (3.13) | 0.48 | 0.98 (3.27) | 0.76 | 1.46 (3.17) | 0.64 |
PR status | ||||||||||
 PR− vs. PR+ | − 4.82 (3.33) | 0.15 | − 6.36 (4.14) | 0.13 | − 4.15 (6.40) | 0.52 | − 6.16 (5.23) | 0.24 | − 3.13 (5.65) | 0.58 |
HER2 status | ||||||||||
 HER2+ vs. HER2− | 2.68 (2.71) | 0.32 | − 0.65 (2.84) | 0.82 | 1.98 (3.83) | 0.61 | 2.00 (3.95) | 0.61 | 0.51 (3.86) | 0.89 |
Breast cancer subtypea | ||||||||||
 Luminal B vs. luminal A | 7.04 (3.87) | 0.07 | 0.94 (3.99) | 0.81 | 3.83 (5.42) | 0.48 | − 0.87 (5.59) | 0.88 | − 6.63 (5.45) | 0.22 |
 HER2-E vs. luminal A | − 1.62 (3.61) | 0.65 | − 7.98 (3.71) | 0.03 | − 0.18 (5.15) | 0.97 | 6.13 (5.31) | 0.25 | 7.97 (5.18) | 0.12 |
 TN vs. luminal A | − 1.01 (2.55) | 0.69 | − 10.57 (2.66) | < 0.0001 | − 0.88 (3.60) | 0.81 | 2.70 (3.71) | 0.47 | 1.88 (3.62) | 0.60 |